Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface

Journal of Infectious Diseases

Volumn 200, Issue 10, 2009, Pages 1583-1592

  Feng, Youjun ^a,c,e   Pan, Xiuzhen ^a,b   Sun, Wen ^a,b,f   Wang, Changjun ^a   Zhang, Huimin ^c   Li, Xianfu ^a   Ma, Ying ^c   Shao, Zhuqing ^a,b   Ge, Junchao ^a,b   Zheng, Feng ^a   Gao, George F ^c,d   Tang, Jiaqi ^a  

^a Research Institute for Medicine of Nanjing Command   (China)

^b NANJING NORMAL UNIVERSITY   (China)

^c CAS Key Laboratory of Pathogenic Microbiology and Immunology

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f Yangzhou Vocational College of Environment and Resources   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; PHOSPHOENOLPYRUVATE; ADHESIN; BACTERIAL ANTIGEN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIUM ADHERENCE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; WESTERN BLOTTING; ANIMAL; CHEMISTRY; COMMUNICABLE DISEASE; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MICROBIOLOGY; SWINE; SWINE DISEASE; VACCINATION; ZOONOSIS;

ADHESINS, BACTERIAL; ANIMALS; ANTIGENS, BACTERIAL; COMMUNICABLE DISEASES, EMERGING; HUMANS; MICE; PHOSPHOPYRUVATE HYDRATASE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SUS SCROFA; SWINE DISEASES; VACCINATION; VIRULENCE FACTORS; ZOONOSES;

EID: 70449723681     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/644602     Document Type: Article

References (40)

1. Gottschalk M, Segura M, Xu J. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev 2007; 8:29-45.
2. Higgins R, Gottschalk M, Boudreau M, Lebrun A, Henrichsen J. Description of six new capsular types (29-34) of Streptococcus suis. J Vet Diagn Invest 1995; 7:405-406
3. Wisselink H, Smith H, Stockhofe-Zurwieden N, Peperkamp K, Vecht U. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet Microbiol 2000; 74:237-248
4. Tang J, Wang C, Feng Y, et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med 2006; 3:e151.
5. Zheng H, Ye C, Segura M, Gottschalk M, Xu J. Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome. Clin Exp Immunol 2008; 153:385-391
6. Feng Y, Shi X, Zhang H, et al. Recurrence of human Streptococcus suis infections in 2007: three cases of meningitis and implications that heterogeneous S. suis 2 circulates in China. Zoonoses Public Health 2009; Jun 17 (epub ahead of print).
7. Pan X, Ge J, Li M, et al. The orphan response regulator CovR: a globally negative modulator of virulence in Streptococcus suis serotype 2. J Bacteriol 2009; 191:2601-2612
8. Ge J, Feng Y, Ji H, et al. Inactivation of dipeptidyl peptidase IV attenuates the virulence of Streptococcus suis serotype 2 that causes streptococcal toxic shock syndrome. Curr Microbiol 2009; 59:248-255
9. Wertheim HF, Nghia HD, Taylor W, Schultsz C. Streptococcus suis: an emerging human pathogen. Clin Infect Dis 2009; 48:617-625
10. Chen C, Tang J, Dong W, et al. A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLoS ONE 2007; 2:e315.
11. Li M, Wang C, Feng Y, et al. SalK/SalR, a two-component signal transduction system, is essential for full virulence of highly invasive Streptococcus suis serotype 2. PLoS ONE 2008; 3:e2080.
12. Wang C, Li M, Feng Y, et al. The involvement of sortase A in high virulence of STSS-causing Streptococcus suis serotype 2. Arch Microbiol 2009; 191:23-33.
13. Vanier G, Sekizaki T, Dominguez-Punaro MC, et al. Disruption of srtA gene in Streptococcus suis results in decreased interactions with endothelial cells and extracellular matrix proteins. Vet Microbiol 2008; 127:417-424
14. Fittipaldi N, Sekizaki T, Takamatsu D, et al. Significant contribution of the pgdA gene to the virulence of Streptococcus suis. Mol Microbiol 2008; 70:1120-1135
15. Feng Y, Li M, Zhang H, et al. Functional definition and global regulation of Zur, a zinc uptake regulator in a Streptococcus suis serotype 2 strain causing streptococcal toxic shock syndrome. J Bacteriol 2008; 190:7567-7578
16. Tang DJ, Li XJ, He YQ, Feng JX, Chen B, Tang JL. The zinc uptake regulator Zur is essential for the full virulence of Xanthomonas campestris pv. campestris. Mol Plant Microbe Interact 2005; 18:652-658 (Pubitemid 40832032) (Pubitemid 40832032)
17. Maione D, Margarit I, Rinaudo CD, et al. Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science 2005; 309:148-150
18. Fluegge K, Schweier O, Schiltz E, Batsford S, Berner R. Identification and immunoreactivity of proteins released from Streptococcus agalactiae. Eur J Clin Microbiol Infect Dis 2004; 23:818-824
19. Hughes MJ, Moore JC, Lane JD, et al. Identification of major outer surface proteins of Streptococcus agalactiae. Infect Immun 2002; 70:1254-1259
20. Fischetti VA. Surface proteins on gram-positive bacteria. In: Fischetti VA, ed. Gram-positive pathogens. Washington, DC: ASM Press, 2000: 11-24.
21. NavarreWW, Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 1999; 63:174-229.
22. Cabanes D, Dehoux P, Dussurget O, Frangeul L, Cossart P. Surface proteins and the pathogenic potential of Listeria monocytogenes. Trends Microbiol 2002; 10:238-245
23. Delgado ML, OConnor JE, Azorín I, Renau-Piqueras J, Gil ML, Gozalbo D. The glyceraldehyde-3-phosphate dehydrogenase polypeptides encoded by the Saccharomyces cerevisiae TDH1, TDH2 and TDH3 genes are also cell wall proteins. Microbiology 2001; 147:411-417 (Pubitemid 32156817)
24. Pancholi V. Multifunctional a-enolase: its role in diseases. Cell Mol Life Sci 2001; 58:902-920 (Pubitemid 32652817)
25. Nombela C, Gil C, Chaffin WL. Non-conventional protein secretion in yeast. Trends Microbiol 2006; 14:15-21.
26. Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in poststreptococcal autoimmune CNS disease. J Neuroimmunol 2006; 172: 187-197 (Pubitemid 43277505) (Pubitemid 43277505)
27. Kolberg J, Aase A, Bergmann S, et al. Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface. Microbiology 2006; 152:1307-1317
28. Eroles P, Sentandreu M, Elorza MV, Sentandreu R. The highly immunogenic enolase and Hsp70p are adventitious Candida albicans cell wall proteins. Microbiology 1997; 143:313-320
29. Kato K, Asai R, Shimizu A, Suzuki F, Ariyoshi Y. Immunoassay of three enolase isozymes in human serum and in blood cells. Clin Chim Acta 1983; 127:353-363 (Pubitemid 13190182) (Pubitemid 13190182)
30. Dinis M, Tavares D, Veiga-Malta I, et al. Oral therapeutic vaccination with Streptococcus sobrinus recombinant enolase confers protection against dental caries in rats. J Infect Dis 2009; 199:116-123
31. Esgleas M, Li Y, Hancock MA, Harel J, Dubreuil JD, Gottschalk M. Isolation and characterization of a-enolase, a novel fibronectin-binding protein from Streptococcus suis. Microbiology 2008; 154:2668-2679
32. Sun W, Pan X, Wang C, et al. Molecular cloning and immunological characterization of enolase from Streptococcus suis 2. Microbiology (Chinese) 2008; 35:15-19
33. Feng Y, Zheng F, Pan X, et al. Existence and characterization of allelic variants of Sao, a newly identified surface protein from Streptococcus suis. FEMS Microbiol Lett 2007; 275:80-88 (Pubitemid 47390090) (Pubitemid 47390090)
34. Li Y, Martinez G, Gottschalk M, et al. Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs. Infect Immun 2006; 74:305-312
35. Zhang A, Chen B, Mu X, et al. Identification and characterization of a novel protective antigen, enolase of Streptococcus suis serotype 2. Vaccine 2009; 27:1348-1353
36. Jacobs AA, Loeffen PL, van den Berg AJ, Storm PK. Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect Immun 1994; 62:1742-1748 (Pubitemid 24136972)
37. Ehinger S, Schubert WD, Bergmann S, Hammerschmidt S, Heinz DW. Plasmin(ogen)-binding a-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites. J Mol Biol 2004; 343:997-1005.
38. Liu L, Cheng G, Wang C, et al. Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis. Curr Microbiol 2009; 58:11-17
39. Eberhard T, Kronvall G, Ullberg M. Surface bound plasmin promotes migration of Streptococcus pneumoniae through reconstituted basement membranes. Microb Pathog 1999; 26:175-181
40. Cork AJ, Jergic S, Hammerschmidt S, et al. Defining the structural basis of human plasminogen binding by streptococcal surface enolase. J Biol Chem 2009; 284:17129-17137